The proposed solutions include education, access and low-cost interventions.
A study says fish oil doesn't lower the risk of heart disease, and the World Health Organization greenlights Pfizer's Prevnar 13 for adults 50 and up.
It's time for a regulatory Marshall plan to help build global systems for quality and safety
*Group discounts available on request
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.